Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Dejan Vidovic"'
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Cutaneous melanoma is relatively common with increasing incidence and significant mortality. While the mainstay of therapy is surgical, patients with stage III and IV disease fare poorer than those with early-stage disease and often benefit from adju
Externí odkaz:
https://doaj.org/article/25bcd5be9efb4bb59e5a80471ef3ccdb
Autor:
Mohammad Sultan, Jacob T. Nearing, Justin M. Brown, Thomas T. Huynh, Brianne M. Cruickshank, Emily Lamoureaux, Dejan Vidovic, Margaret L. Dahn, Wasundara Fernando, Krysta M. Coyle, Carman A. Giacomantonio, Morgan G.I. Langille, Paola Marcato
Publikováno v:
Molecular Oncology, Vol 15, Iss 8, Pp 2046-2064 (2021)
Paclitaxel is a common breast cancer drug; however, some tumors are resistant. The identification of biomarkers for paclitaxel resistance or sensitivity would enable the development of strategies to improve treatment efficacy. A genome‐wide in vivo
Externí odkaz:
https://doaj.org/article/b727d6306bc6474fa6e0ff5f6052d777
Autor:
Ashley Drohan, Dejan Vidovic, Penelope Jane Barnes, Carman Anthony Giacomantonio, Lucy Kathryn Helyer
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Breast cancer is the most common non-cutaneous cancer affecting women worldwide and is a major cause of cancer-related morbidity and mortality in females. While many women are diagnosed with early-stage disease, a subset of women may present with iso
Externí odkaz:
https://doaj.org/article/ab4459373db14f21afb15224d1b3332e
Autor:
Dejan Vidovic, Gordon A. Simms, Sylvia Pasternak, Mark Walsh, Kevork Peltekian, John Stein, Lucy K. Helyer, Carman A. Giacomantonio
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer worldwide, with ever increasing incidence and mortality. While most patients can be treated successfully with surgical excision, cryotherapy, or radiation the
Externí odkaz:
https://doaj.org/article/a18e403f4865409a8edb45175fccdded
Autor:
Brianne M. Cruickshank, Marie-Claire D. Wasson, Justin M. Brown, Wasundara Fernando, Jaganathan Venkatesh, Olivia L. Walker, Fiorella Morales-Quintanilla, Margaret L. Dahn, Dejan Vidovic, Cheryl A. Dean, Carter VanIderstine, Graham Dellaire, Paola Marcato
Publikováno v:
Cancers, Vol 13, Iss 11, p 2644 (2021)
Triple-negative breast cancers (TNBCs) are aggressive, lack targeted therapies and are enriched in cancer stem cells (CSCs). Novel therapies which target CSCs within these tumors would likely lead to improved outcomes for TNBC patients. Long non-codi
Externí odkaz:
https://doaj.org/article/efc28cf05d8145abbe04f8a5ab7aaedc
Autor:
Dejan Vidovic, Carman Giacomantonio
Publikováno v:
Cancers, Vol 12, Iss 5, p 1321 (2020)
The incidence of cutaneous melanoma, a highly malignant skin cancer, is increasing yearly. While surgical removal of the tumor is the mainstay of treatment for patients with locally confined disease, those with metastases face uncertainty when it com
Externí odkaz:
https://doaj.org/article/fd9060fd25bc48c9afa3e06d1a75f352
Autor:
Krysta M. Coyle, Wasundara Fernando, Emily Lamoureaux, Paola Marcato, Carman A. Giacomantonio, Mohammad Sultan, Brianne M. Cruickshank, Margaret L. Dahn, Justin M Brown, Dejan Vidovic, Morgan G. I. Langille, Jacob T. Nearing, Thomas T. Huynh
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 15, Iss 8, Pp 2046-2064 (2021)
Molecular Oncology, Vol 15, Iss 8, Pp 2046-2064 (2021)
Paclitaxel is a common breast cancer drug; however, some tumors are resistant. The identification of biomarkers for paclitaxel resistance or sensitivity would enable the development of strategies to improve treatment efficacy. A genome‐wide in vivo
Autor:
Krysta Mila Coyle, Cheryl A. Dean, Margaret Lois Thomas, Dejan Vidovic, Carman A. Giacomantonio, Lucy Helyer, Paola Marcato
Publikováno v:
Cancers, Vol 10, Iss 11, p 397 (2018)
All-trans retinoic acid (atRA) regulates gene expression and is used to treat acute promyelocytic leukemia. Attempts to use atRA in breast cancer without a stratification strategy have resulted in limited overall effectiveness. To identify biomarkers
Externí odkaz:
https://doaj.org/article/646ea65586394818b1dda4929195b0e9
Autor:
Olivia L Walker, Justin M Brown, Cheryl A. Dean, Wasundara Fernando, Paola Marcato, Graham Dellaire, Brianne M. Cruickshank, Margaret L. Dahn, Marie-Claire D Wasson, Dejan Vidovic, Carter VanIderstine, Fiorella Morales-Quintanilla, Jaganathan Venkatesh
Publikováno v:
Cancers
Volume 13
Issue 11
Cancers, Vol 13, Iss 2644, p 2644 (2021)
Volume 13
Issue 11
Cancers, Vol 13, Iss 2644, p 2644 (2021)
Triple-negative breast cancers (TNBCs) are aggressive, lack targeted therapies and are enriched in cancer stem cells (CSCs). Novel therapies which target CSCs within these tumors would likely lead to improved outcomes for TNBC patients. Long non-codi
Autor:
Mark Walsh, Carman A. Giacomantonio, John Stein, Dejan Vidovic, Lucy Helyer, Gordon A. Simms, Kevork M. Peltekian, Sylvia Pasternak
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
Cutaneous squamous cell carcinoma (cSCC) is the second most common non-melanoma skin cancer worldwide, with ever increasing incidence and mortality. While most patients can be treated successfully with surgical excision, cryotherapy, or radiation the